Elio L. Herzog

Elio L. Herzog

Auto-generated profile, based on publicly available information

Elio L. Herzog

Affiliations Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland, Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EHElio L. Herzog
Elio L. Herzog
MWMelania Wäfler
Melania Wäfler
IKIrene Keller
Irene Keller
SWSebastian Wolf
Sebastian Wolf
MZMartin S. Zinkernagel
Martin S. Zinkernagel
DZDenise C. Zysset-Burri
Denise C. Zysset-Burri
The intestinal microbiome plays a central role in human health and disease. While its composition is relatively stable throughout adulthood, the microbial balance starts to decrease in later life stages. Thus, in order to maintain a good quality of life, including the prevention of age-associated diseases in the elderly, it is important to understand the dynamics of the intestinal microbiome. In this study, stool samples of 278 participants were sequenced by whole metagenome shotgun sequencing and their taxonomic and functional profiles characterized. The two age groups, below65 and above65, could be separated based on taxonomic and associated functional features using Multivariate Association of Linear Models. In a second approach, through machine learning, biomarkers connecting the intestinal microbiome with age were identified. These results reflect the importance to select age-matched study groups for unbiased metagenomic data analysis and the possibility to generate robust data by applying independent algorithms for data analysis. Furthermore, since the intestinal microbiome can be modulated by antibiotics and probiotics, the data of this study may have implications on preventive strategies of age-associated degradation processes and diseases by microbiome-altering interventions.